Somatic mutations of the MEN1 tumor suppressor gene detected in sporadic angiofibromas. 1998

R Böni, and A O Vortmeyer, and S Pack, and W S Park, and G Burg, and G Hofbauer, and T Darling, and L Liotta, and Z Zhuang

UI MeSH Term Description Entries
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D010507 Periodicity The tendency of a phenomenon to recur at regular intervals; in biological systems, the recurrence of certain activities (including hormonal, cellular, neural) may be annual, seasonal, monthly, daily, or more frequently (ultradian). Cyclicity,Rhythmicity,Biological Rhythms,Bioperiodicity,Biorhythms,Biological Rhythm,Bioperiodicities,Biorhythm,Cyclicities,Periodicities,Rhythm, Biological,Rhythmicities,Rhythms, Biological
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm
D016147 Genes, Tumor Suppressor Genes that inhibit expression of the tumorigenic phenotype. They are normally involved in holding cellular growth in check. When tumor suppressor genes are inactivated or lost, a barrier to normal proliferation is removed and unregulated growth is possible. Antioncogenes,Cancer Suppressor Genes,Emerogenes,Genes, Cancer Suppressor,Genes, Growth Suppressor,Genes, Metastasis Suppressor,Growth Suppressor Genes,Metastasis Suppressor Genes,Tumor Suppressor Genes,Anti-Oncogenes,Genes, Onco-Suppressor,Oncogenes, Recessive,Tumor Suppressing Genes,Anti Oncogenes,Anti-Oncogene,Antioncogene,Cancer Suppressor Gene,Emerogene,Gene, Cancer Suppressor,Gene, Growth Suppressor,Gene, Metastasis Suppressor,Gene, Onco-Suppressor,Gene, Tumor Suppressing,Gene, Tumor Suppressor,Genes, Onco Suppressor,Genes, Tumor Suppressing,Growth Suppressor Gene,Metastasis Suppressor Gene,Onco-Suppressor Gene,Onco-Suppressor Genes,Oncogene, Recessive,Recessive Oncogene,Recessive Oncogenes,Suppressor Gene, Cancer,Suppressor Gene, Growth,Suppressor Gene, Metastasis,Suppressor Genes, Cancer,Suppressor Genes, Growth,Suppressor Genes, Metastasis,Tumor Suppressing Gene,Tumor Suppressor Gene
D017422 Sequence Analysis, DNA A multistage process that includes cloning, physical mapping, subcloning, determination of the DNA SEQUENCE, and information analysis. DNA Sequence Analysis,Sequence Determination, DNA,Analysis, DNA Sequence,DNA Sequence Determination,DNA Sequence Determinations,DNA Sequencing,Determination, DNA Sequence,Determinations, DNA Sequence,Sequence Determinations, DNA,Analyses, DNA Sequence,DNA Sequence Analyses,Sequence Analyses, DNA,Sequencing, DNA
D018322 Angiofibroma A benign neoplasm of fibrous tissue in which there are numerous small and large, frequently dilated, vascular channels. (Stedman, 25th ed) Angiofibromas
D018761 Multiple Endocrine Neoplasia Type 1 A form of multiple endocrine neoplasia that is characterized by the combined occurrence of tumors in the PARATHYROID GLANDS, the PITUITARY GLAND, and the PANCREATIC ISLETS. The resulting clinical signs include HYPERPARATHYROIDISM; HYPERCALCEMIA; HYPERPROLACTINEMIA; CUSHING DISEASE; GASTRINOMA; and ZOLLINGER-ELLISON SYNDROME. This disease is due to loss-of-function of the MEN1 gene, a tumor suppressor gene (GENES, TUMOR SUPPRESSOR) on CHROMOSOME 11 (Locus: 11q13). Neoplasia, Multiple Endocrine Type 1,Neoplasms, Multiple Endocrine Type 1,Wermer Syndrome,Multiple Endocrine Neoplasia Type I,Multiple Endocrine Neoplasms Type 1,Neoplasms, Multiple Endocrine Type I

Related Publications

R Böni, and A O Vortmeyer, and S Pack, and W S Park, and G Burg, and G Hofbauer, and T Darling, and L Liotta, and Z Zhuang
November 1997, Cancer research,
R Böni, and A O Vortmeyer, and S Pack, and W S Park, and G Burg, and G Hofbauer, and T Darling, and L Liotta, and Z Zhuang
July 1999, Cancer letters,
R Böni, and A O Vortmeyer, and S Pack, and W S Park, and G Burg, and G Hofbauer, and T Darling, and L Liotta, and Z Zhuang
May 2000, Journal of endocrinological investigation,
R Böni, and A O Vortmeyer, and S Pack, and W S Park, and G Burg, and G Hofbauer, and T Darling, and L Liotta, and Z Zhuang
October 2000, British journal of cancer,
R Böni, and A O Vortmeyer, and S Pack, and W S Park, and G Burg, and G Hofbauer, and T Darling, and L Liotta, and Z Zhuang
November 1998, Genes, chromosomes & cancer,
R Böni, and A O Vortmeyer, and S Pack, and W S Park, and G Burg, and G Hofbauer, and T Darling, and L Liotta, and Z Zhuang
December 1997, Cancer research,
R Böni, and A O Vortmeyer, and S Pack, and W S Park, and G Burg, and G Hofbauer, and T Darling, and L Liotta, and Z Zhuang
April 1998, The Journal of clinical endocrinology and metabolism,
R Böni, and A O Vortmeyer, and S Pack, and W S Park, and G Burg, and G Hofbauer, and T Darling, and L Liotta, and Z Zhuang
January 2002, Cancer letters,
R Böni, and A O Vortmeyer, and S Pack, and W S Park, and G Burg, and G Hofbauer, and T Darling, and L Liotta, and Z Zhuang
February 2018, FEBS open bio,
R Böni, and A O Vortmeyer, and S Pack, and W S Park, and G Burg, and G Hofbauer, and T Darling, and L Liotta, and Z Zhuang
February 1998, Cancer research,
Copied contents to your clipboard!